Incomplete Excision Rate for Lentigo Maligna and Associated Risk Factors
DOI:
https://doi.org/10.2340/actadv.v104.40535Keywords:
Dermatologic surgical procedures, incomplete excision, lentigo maligna, margins of excision, melanoma, surgeryAbstract
Standard treatment for lentigo maligna (LM) is surgical excision, yet insights into the frequency of and risk factors for incomplete excisions remain limited. The primary objectives were to assess the incomplete excision rate (IER) in primary LM and to explore potential risk factors for incomplete excisions. A retrospective analysis was conducted encompassing consecutive histopathologically confirmed LMs from 2014–2020. Descriptive statistics were used for LM characteristics and IER, while uni- and multivariate analyses were used for calculating risk factors. The study included 395 LMs with an IER of 16.7% (n = 66). Risk factors for higher incomplete excision rates included: head and neck lesions (p = 0.0014), clinical excision margins < 5 mm (p = 0.040), and utilization of preoperative partial biopsies (p = 0.023). Plastic surgeons had higher IERs than dermatologists (p = 0.036). Lesion diameter (p = 0.20) and surgeon experience (p = 0.20) showed no associations with incomplete excisions, yet LMs with a diameter ≥ 20 mm exhibited higher incomplete excision rates (23.2%) compared witho those < 10 mm (12.9%). LMs should be excised with at least 5-mm clinical margins, especially in the head and neck area. LMs ≥ 20 mm may be more surgically challenging. High-er incomplete excision rates associated with the use of preoperative biopsies and/or plastic surgeons may reflect challenging anatomical locations, larger lesion diameter, and/or ill-defined borders.
Downloads
References
Shain AH, Bastian BC. From melanocytes to melanomas. Nat Rev Cancer 2016; 16: 345-358.
https://doi.org/10.1038/nrc.2016.37 DOI: https://doi.org/10.1038/nrc.2016.37
Tanaka M, Sawada M, Kobayashi K. Key points in dermoscopic differentiation between lentigo maligna and solar lentigo. J Dermatol 2011; 38: 53-58.
https://doi.org/10.1111/j.1346-8138.2010.01132.x DOI: https://doi.org/10.1111/j.1346-8138.2010.01132.x
Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987; 116: 303-310.
https://doi.org/10.1111/j.1365-2133.1987.tb05843.x DOI: https://doi.org/10.1111/j.1365-2133.1987.tb05843.x
The Swedish Cancer Registry of the National Board of Health and Welfare. [Cancer incidence in Sweden 2022]. 2023. Available from: http://www.socialstyrelsen.se.
Collgros H, Rodriguez-Lomba E, Regio Pereira A, Lo SN, Scolyer RA, Guitera P. Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre. J Eur Acad Dermatol Venereol 2021; 35: 1315-1322.
https://doi.org/10.1111/jdv.17135 DOI: https://doi.org/10.1111/jdv.17135
Friedman EB, Scolyer RA, Williams GJ, Thompson JF. Melanoma in situ: a critical review and re-evaluation of current excision margin recommendations. Adv Ther 2021; 38: 3506-3530.
https://doi.org/10.1007/s12325-021-01783-x DOI: https://doi.org/10.1007/s12325-021-01783-x
Lallas A, Tschandl P, Kyrgidis A, Stolz W, Rabinovitz H, Cameron A, et al. Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis. Br J Dermatol 2016; 174: 1079-1085.
https://doi.org/10.1111/bjd.14355 DOI: https://doi.org/10.1111/bjd.14355
Iznardo H, Garcia-Melendo C, Yelamos O. Lentigo maligna: clinical presentation and appropriate management. Clin Cosmet Investig Dermatol 2020; 13: 837-855.
https://doi.org/10.2147/CCID.S224738 DOI: https://doi.org/10.2147/CCID.S224738
Ozbagcivan O, Akarsu S, Ikiz N, Semiz F, Fetil E. Dermoscopic differentiation of facial lentigo maligna from pigmented actinic keratosis and solar lentigines. Acta Dermatovenerol Croat 2019; 27: 146-152.
Elshot YS, Tio D, van Haersma-de With ASE, Ouwerkerk W, Zupan-Kajcovski B, Crijns MB, et al. Lentigo maligna (melanoma): A systematic review and meta-analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy. J Eur Acad Dermatol Venereol 2023; 37: 871-883.
https://doi.org/10.1111/jdv.18880 DOI: https://doi.org/10.1111/jdv.18880
Fallowfield ME, Curley RK, Cook MG. Melanocytic lesions and melanocyte populations in human epidermis. Br J Dermatol 1991; 124: 130-134.
https://doi.org/10.1111/j.1365-2133.1991.tb00421.x DOI: https://doi.org/10.1111/j.1365-2133.1991.tb00421.x
Weyers W, Bonczkowitz M, Weyers I, Bittinger A, Schill WB. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol 1996; 18: 560-566.
https://doi.org/10.1097/00000372-199612000-00002 DOI: https://doi.org/10.1097/00000372-199612000-00002
Regionala cancercentrum, RCC, Sweden. National guidelines melanoma. Version 7.4, November 14 - 2023. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/melanom/vardprogram/
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022. Eur J Cancer 2022; 170: 256-284.
https://doi.org/10.1016/j.ejca.2022.04.018 DOI: https://doi.org/10.1016/j.ejca.2022.04.018
National Comprehensive Cancer Network, NCCN Guidelines®, Melanoma: Cutaneous. Version 1.2024 - February 12, 2024. Available from: https://www.nccn.org/guidelines/ category_1
Hilari H, Llorca D, Traves V, Villanueva A, Serra-Guillén C, Requena C, et al. Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas Dermosifiliogr 2012; 103: 614-623. DOI: https://doi.org/10.1016/j.adengl.2012.08.014
https://doi.org/10.1016/j.ad.2011.12.009 DOI: https://doi.org/10.1016/j.ad.2011.12.009
Huilgol SC, Selva D, Chen C, Hill DC, James CL, Gramp A, Malhotra R. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol 2004; 140: 1087-1092.
https://doi.org/10.1001/archderm.140.9.1087 DOI: https://doi.org/10.1001/archderm.140.9.1087
Kunishige JH, Doan L, Brodland DG, Zitelli JA. Comparison of surgical margins for lentigo maligna versus melanoma in situ. J Am Acad Dermatol 2019; 81: 204-212.
https://doi.org/10.1016/j.jaad.2019.01.051 DOI: https://doi.org/10.1016/j.jaad.2019.01.051
Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 2002; 47: 743-748.
https://doi.org/10.1067/mjd.2002.124085 DOI: https://doi.org/10.1067/mjd.2002.124085
Akhtar S, Bhat W, Magdum A, Stanley PR. Surgical excision margins for melanoma in situ. J Plast Reconstr Aesthet Surg 2014; 67: 320-323.
https://doi.org/10.1016/j.bjps.2013.11.014 DOI: https://doi.org/10.1016/j.bjps.2013.11.014
Hou JL, Reed KB, Knudson RM, Mirzoyev SA, Lohse CM, Frohm ML, et al. Five-year outcomes of wide excision and Mohs micrographic surgery for primary lentigo maligna in an academic practice cohort. Dermatol Surg 2015; 41: 211-218.
https://doi.org/10.1097/DSS.0000000000000248 DOI: https://doi.org/10.1097/DSS.0000000000000248
Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg 2002; 55: 611-615.
https://doi.org/10.1054/bjps.2002.3967 DOI: https://doi.org/10.1054/bjps.2002.3967
Navarrete-Dechent C, Aleissa S, Connolly K, Hibler BP, Dusza SW, Rossi AM, et al. Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type. J Am Acad Dermatol 2021; 84: 1295-1301.
https://doi.org/10.1016/j.jaad.2020.10.023 DOI: https://doi.org/10.1016/j.jaad.2020.10.023
Gorman M, Khan MA, Johnson PC, Hart A, Mathew B. A model for lentigo maligna recurrence using melanocyte count as a predictive marker based upon logistic regression analysis of a blinded retrospective review. J Plast Reconstr Aesthet Surg 2014; 67: 1322-1332.
https://doi.org/10.1016/j.bjps.2014.05.058 DOI: https://doi.org/10.1016/j.bjps.2014.05.058
Mu EW, Quatrano NA, Yagerman SE, Ratner D, Meehan SA. Evaluation of MITF, SOX10, MART-1, and R21 immunostaining for the diagnosis of residual melanoma in situ on chronically sun-damaged skin. Dermatol Surg 2018; 44: 933-938
https://doi.org/10.1097/DSS.0000000000001493 DOI: https://doi.org/10.1097/DSS.0000000000001493
Siarov J, Neittaanmäki N, Mölne J, Gillstedt M, Paoli J. Digital Quantification of Melanocytic Density in Resection Margins of Lentigo Maligna Using SOX10 Versus Hematoxylin-Eosin Staining. Am J Dermatopathol 2021; 43: 273-277.
https://doi.org/10.1097/DAD.0000000000001749 DOI: https://doi.org/10.1097/DAD.0000000000001749
Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 1997; 37: 422-429. DOI: https://doi.org/10.1016/S0190-9622(18)30743-6
https://doi.org/10.1016/S0190-9622(97)70144-0 DOI: https://doi.org/10.1016/S0190-9622(97)70144-0
Ellison PM, Zitelli JA, Brodland DG. Mohs micrographic surgery for melanoma: A prospective multicenter study. J Am Acad Dermatol 2019; 81: 767-774.
https://doi.org/10.1016/j.jaad.2019.05.057 DOI: https://doi.org/10.1016/j.jaad.2019.05.057
Moyer JS, Rudy S, Boonstra PS, Kraft C, Chinn SB, Baker SR, et al. Efficacy of staged excision with permanent section margin control for cutaneous head and neck melanoma. JAMA Dermatol 2017; 153: 282-288.
https://doi.org/10.1001/jamadermatol.2016.4603 DOI: https://doi.org/10.1001/jamadermatol.2016.4603
Shin TM, Etzkorn JR, Sobanko JF, Margolis DJ, Gelfand JM, Chu EY, et al. Clinical factors associated with subclinical spread of in situ melanoma. J Am Acad Dermatol 2017; 76: 707-713.
https://doi.org/10.1016/j.jaad.2016.10.049 DOI: https://doi.org/10.1016/j.jaad.2016.10.049
Wilson JB, Walling HW, Scupham RK, Bean AK, Ceilley RI, Goetz KE. Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice. J Clin Aesthet Dermatol 2016; 9: 25-30.
Eckardt J, Behrens V, Kofler K, Forchhammer S, Hafner HM, Kofler L. The impact of haematoxylin-eosin staining and immunohistochemistry of lentigo maligna and lentigo maligna melanoma margins on local recurrence. Eur J Dermatol 2022; 32: 750-755.
https://doi.org/10.1684/ejd.2022.4379 DOI: https://doi.org/10.1684/ejd.2022.4379
de Waal J. Skin tumour specimen shrinkage with excision and formalin fixation-how much and why: a prospective study and discussion of the literature. ANZ J Surg 2021; 91: 2744-2749.
https://doi.org/10.1111/ans.17109 DOI: https://doi.org/10.1111/ans.17109
Published
How to Cite
License
Copyright (c) 2024 Maja Modin, Helena Svensson, Ylva Bergsten Wanders, Noora Neittanmäki, Jan Siarov, John Paoli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
